A POPULATION-BASED STUDY OF PROGNOSTIC FACTORS IN ORAL AND OROPHARYNGEAL CANCER

被引:15
|
作者
BOFFETTA, P
MERLETTI, F
MAGNANI, C
TERRACINI, B
机构
[1] UNIV TURIN,CANC EPIDEMIOL UNIT,I-10126 TURIN,ITALY
[2] NOVARRA MED SCH,DEPT MED SCI,I-28100 NOVARA,ITALY
来源
关键词
ORAL CAVITY CANCER; OROPHARYNGEAL CANCER; SURVIVAL; PROGNOSTIC FACTORS;
D O I
10.1016/0964-1955(94)90013-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cases of oral cavity and oropharynx cancer diagnosed among the residents of Torino, Italy, between 1982 and 1984 (n=143) were followed up to June 1990. During this period, 97 subjects (67.8%) died, 69 from oral or oropharyngeal cancer. 10 more cases died from causes possibly related to oral cancer. The overall relative 5-year survival rate was 37.2%. Men experienced a worse survival than women. No difference was shown according to age, education or occupation. Patients with smooth lesions had a poorer prognosis than those with fissured or granular lesions; no association between survival;and colour, elevation, induration or bleeding from the lesion was found. Extension of the tumour and nodal involvement were strong and independent predictors of survival, but no difference was found between T1 and T2 lesions. Patients who reported a 2-3-month interval between onset of symptoms and diagnosis experienced a better survival than those with shorter or longer interval. Oropharynx cases had a better prognosis than cancers of the oral cavity.
引用
收藏
页码:369 / 373
页数:5
相关论文
共 50 条
  • [1] Prognostic factors in epithelial ovarian cancer: A population-based study
    Chang, Lin-Chau
    Huang, Chih-Fen
    Lai, Mei-Shu
    Shen, Li-Jiuan
    Wu, Fe-Lin Lin
    Cheng, Wen-Fang
    PLOS ONE, 2018, 13 (03):
  • [2] Prognostic factors in male breast cancer: a population-based study
    Leone, Jose Pablo
    Osvaldo Zwenger, Ariel
    Iturbe, Julian
    Leone, Julieta
    Amadeo Leone, Bernardo
    Teodoro Vallejo, Carlos
    Bhargava, Rohit
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 156 (03) : 539 - 548
  • [3] Prognostic factors in male breast cancer: A population-based study
    Leone, J. P.
    Zwenger, A. O.
    Iturbe, J.
    Leone, J.
    Leone, B. A.
    Vallejo, C. T.
    Bhargava, R.
    CANCER RESEARCH, 2016, 76
  • [4] Prognostic factors in male breast cancer: a population-based study
    José Pablo Leone
    Ariel Osvaldo Zwenger
    Julián Iturbe
    Julieta Leone
    Bernardo Amadeo Leone
    Carlos Teodoro Vallejo
    Rohit Bhargava
    Breast Cancer Research and Treatment, 2016, 156 : 539 - 548
  • [5] Prognostic factors for survival in pancreatic cancer: A population-based study
    Eloubeidi, Mohamad
    Desmond, Renee
    Wilcox, Charles M.
    Wilson, Reda
    Manchikalapti, Pavan
    Fouad, Mona
    Eltoum, Isam
    Vickers, Selwyn
    GASTROENTEROLOGY, 2006, 130 (04) : A424 - A424
  • [6] Prognostic factors for survival in pancreatic cancer: a population-based study
    Eloubeidi, Mohamad A.
    Desmond, Renee A.
    Wilcox, C. Mel
    Wilson, Reda J.
    Manchikalapati, Pavan
    Fouad, Mona M.
    Eltoum, Isam
    Vickers, Selwyn M.
    AMERICAN JOURNAL OF SURGERY, 2006, 192 (03): : 322 - 329
  • [7] International incidence of oropharyngeal cancer: A population-based study
    Cancela, Marianna de Camargo
    Leandro Bezerra de Souza, Dyego
    Curado, Maria Paula
    ORAL ONCOLOGY, 2012, 48 (06) : 484 - 490
  • [8] Prognostic Factors for Bladder Cancer Patients in Malaysia: A Population-Based Study
    Ab Kadir, Mohd Nasrullah Nik
    Hairon, Suhaily Mohd
    Yaacob, Najib Majdi
    Ab Manan, Azizah
    Ali, Nabihah
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (05)
  • [9] Population-based study of prognostic factors in stage II colonic cancer
    Morris, M.
    Platell, C.
    de Boer, B.
    McCaul, K.
    Iacopetta, B.
    BRITISH JOURNAL OF SURGERY, 2006, 93 (07) : 866 - 871
  • [10] Prognostic factors of primary neuroendocrine breast cancer: A population-based study
    Ma, Shu-tao
    Wang, Ding-yuan
    Liu, Yi-bing
    Tan, Hui-jing
    Ge, Yue-yue
    Chi, Yihebali
    Zhang, Bai-lin
    CANCER MEDICINE, 2022, 11 (13): : 2533 - 2540